Insights on the UK Graves’ disease Market to 2019 | Industry Statistics, Emerging Demands, Forecast to 2025
UK Graves’ disease market is growing at a CAGR of around 4.1% during the forecast period. Grave’s disease is one of the most prevalent autoimmune diseases across the UK. It is one of the leading causes of hyperthyroidism in the country. The disease is caused by a number of factors including the sedentary lifestyles, changing eating pattern, the prevalence of diabetes in the country are few of the key reasons which are expected to promote the demand of treatment and diagnostic services, which in turn increases the UK Graves’ disease market. The prevalence of diabetes has increased significantly in the UK. According to The British Diabetic Association 2017, nearly 3.7 million people were diagnosed with diabetes. Amongst this 10 %, people have type-1 diabetes. As the prevalence of such disease increases in the country, the risk associated with Grave’s disease is also increasing, thereby creating opportunities for the growth of the UK Graves’ disease market during the forecast period.
To Request a Sample of our Report on UK
Graves’ disease Market: https://www.omrglobal.com/request-sample/uk-graves-disease-market
Further, the prevalence of
Grave’s’ disease is majorly amongst the age group of 19-54. According to
Eurostat, the working-age population in the UK accounted for 64.4% of the
overall population. The prevalence of Grave’s disease also increases with
changes in unhealthy eating patterns and smoking practices. It is observed that
smoking is one of the key reasons which promote the prevalence of Grave’s
disease in the working-age population. The percentage of population smoking in
the UK is majorly between the age group of 25-34. Owing to this, the prevalence
of Grave’s disease is expected to increase, thereby creating opportunities for
the growth of the UK Graves’ disease market.
In addition, government
initiative including the European Thyroid Association that has laid down numerous
guidelines for the treatment of Grave’s hyperthyroid is also augmenting the
market growth. As technology advances, the adoption of the surgical process for
the treatment of Grave’s disease is expected to increase significantly in the
coming years. Owing to this the proportion of patients treated from
thyroidectomy is more from the Grave’s disease. This is expected to promote the
growth of the UK Graves’ disease market in the near future.
(Get 15% Discount on Buying this Report)
A
full Report of UK Graves’ disease Market is Available @ https://www.omrglobal.com/industry-reports/uk-graves-disease-market
UK Graves’ Disease Market Segmentation
By Diagnosis
·
Ultrasound
·
Imaging Tests
·
Radioactive Iodine Uptake
·
Blood Sample
By Treatment
·
Anti- Thyroid Medication
·
Radioactive Iodine Therapy
·
Surgery
Company Profiles
·
Abbott Laboratories Inc.
·
Allergan PLC
·
Eli Lilly and Co.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Merck & Co. Inc.
·
Mylan NV
·
Novartis International AG
·
Pfizer Inc.
·
Sanofi SA
·
Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment